Completed
Study to Investigate Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of GSK2646264
NCT02424799
- Conditions
- Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +4 more
- Locations
-
- GSK Investigational Site Berlin, Germany
- GSK Investigational Site Berlin, Germany
- GSK Investigational Site Norwich, Norfolk, United Kingdom
- GSK Investigational Site Norwich, Norfolk, United Kingdom